Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
FDA grants accelerated approval to dostarlimab for rectal cancerOct 19Regulatory decisiondostarlimab-gxlyGlaxoSmithKline
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated
GSK registers Phase 3 trials for mRNA flu vaccine and prostate cancer ADC Ris-RezSep 4Weekly roundup, 2 itemsGlaxoSmithKlinerisvutatug rezetecan
Hansoh's Ris-Rez hits PFS endpoint in second phase III osteosarcoma trialJul 28Clinical readoutGlaxoSmithKlinerisvutatug rezetecan